biotech
New York in $500 million de Blasio-backed biotech boost
December 14, 2016Manufacturing and Production, Research and Development New York, biotech, funding
Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …
DNA damage response biotech launches with £25m funding
September 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dna damage response, funding
Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …
13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target
August 16, 2016Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin
Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …
Allergan set to acquire eye-care biotech ForSight VISION5
August 12, 2016Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care
Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …
Amgen’s denosumab may help check breast cancer in women with BRCA1 gene – Study
June 21, 2016Manufacturing and Production, Research and Development Amgen, Prolia, Xgeva, biotech, breast cancer, drug trial, genetics
US biotech firm Amgen’s (Nasdaq: AMGN) Prolia (denosumab) to treat osteoporosis and Xgeva to prevent fractures in cancer patients, may …
UK biotech in great shape, according to new industry report
June 16, 2016Research and Development Europe, UK, biotech, uk bioindustry association
The UK biotechnology sector is going from strength to strength, having raised an “unprecedented” £900 million on the London Stock …
US biotech company to try resurrect the clinically dead
May 4, 2016Research and Development US, bioquark, biotech, brain, central nervous system, clinically dead, dead, patients, ressurect
A US biotech firm has announced plans for a Phase I trial that will see them attempt to bring brain-dead …
Biogen Q1 profits rise boosted by Tecfidera sales
April 22, 2016Medical Communications, Sales and Marketing Biogen, Q1, biotech, earnings, results, tecfidera
Shares in Biogen (Nasdaq: BIIB) climbed to close up over 5% Thursday after the company reported 18% rise in first-quarter …
Vectura agree £441m merger with Skyepharma
March 16, 2016Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura
Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …
Novartis forms Mereo as UK biotech spin-off
July 29, 2015Research and Development Mereo, Novartis, biotech, rare diseases
Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …
Horizon forms new cancer advisory board
November 12, 2014Research and Development, Sales and Marketing Cambridge, Horizon Discovery, Karin Schmitt, Paul Morrill, biotech, sab
UK biotech Horizon Discovery has formed a new Scientific Advisory Board (SAB) for its diagnostics arm to recommend better cancer …
Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Biotech industry failed by UK, says UCB
February 27, 2014Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat
The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …
Amgen commits $2.5 million to biotech educational grants
November 12, 2013Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem
The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …
£10 million boost for synthetic biology
November 6, 2013Research and Development, Sales and Marketing Biological, Synthetic, biotech
The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …
Latest content
